Insider trade

Thermo Fisher Scientific (TMO): Executive Vice President sold ~$1.3M

Gianluca Pettiti, Executive Vice President at Thermo Fisher Scientific, sold ~$1.3M of Thermo Fisher Scientific shares.

~$1.3M
Approx. value · 2,250 sh @ $580.00
21K
Holds after · shares reported
Traded
Nov 10, 2025
Filed
Nov 12, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 23, 2024Congress · 1 personMembers of Congress: 2 purchases
  2. Oct 29, 2024CongressDisclosed purchase of TMO — reported range $1,001 - $15,000
  3. Mar 3, 2025CongressDisclosed sale of TMO — reported range $1,001 - $15,000
  4. Apr 28, 2025CongressDisclosed sale of TMO — reported range $1,001 - $15,000
  5. Jun 6, 2025CongressDisclosed purchase of TMO — reported range $1,001 - $15,000
  6. Jul 25, 2025CongressDisclosed purchase of TMO — reported range $1,001 - $15,000
  7. Aug 19, 2025Congress · 1 personMembers of Congress: 4 sales
  8. Sep 23, 2025CongressDisclosed sale of TMO — reported range $1,001 - $15,000
  9. Sep 25, 2025FDAFDA device clearance: The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Colistin in the dilution range of 0.12-16 ug/mL
  10. Oct 7, 2025Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
  11. Oct 22, 2025Company filing · Form 8-K · ResultsReported its results
  12. Oct 24, 2025Insider · 2 peopleInsiders: 6 sales (~$10.0M)
  13. Oct 27, 2025Insider · 1 personInsiders: 11 sales (~$4.1M)
  14. Oct 30, 2025Congress · 1 personMembers of Congress: 1 purchase, 1 sale
  15. Oct 31, 2025CongressDisclosed sale of TMO — reported range $1,001 - $15,000
  16. Nov 7, 2025Insider · 1 personInsiders: 2 sales (~$5.8M)
  17. Nov 10, 2025 · this disclosureInsiderOfficer sold ~$1.3M of TMO shares in the open market

What came next

  1. Nov 10, 2025InsiderOfficer sold ~$421K of TMO shares in the open market
  2. Nov 12, 2025InsiderOfficer sold ~$622K of TMO shares in the open market
  3. Nov 13, 2025InsiderOfficer sold ~$2.76M of TMO shares in the open market
  4. Nov 24, 2025Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
  5. Nov 25, 2025Insider · 1 personInsiders: 2 sales (~$6.4M)
  6. Dec 1, 2025InsiderOfficer sold ~$4.13M of TMO shares in the open market
  7. Dec 2, 2025Insider · 2 peopleInsiders: 2 sales (~$21.5M)
  8. Dec 3, 2025Insider · 1 personInsiders: 2 sales (~$18.7M)
  9. Dec 4, 2025InsiderOfficer sold ~$12.4M of TMO shares in the open market
  10. Dec 5, 2025FDAFDA device clearance: Thermo Scientific Oxoid Gepotidacin Disc (10 µg) GEP10
  11. Jan 12, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“Each of Michel Lagarde and Frederick M. Lowery have notified Thermo Fisher Scientific Inc. (the “Company”) of their decisions to leave the Company to pursue other opportunities.”
  12. Jan 27, 2026Layoff notice · 5781 Van Allen Way Carlsbad CA 92008Layoff notice filed in CA: 173 employees
  13. Jan 29, 2026Company filing · Form 8-K · ResultsReported its results
  14. Feb 9, 2026Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
  15. Feb 9, 2026InsiderOfficer sold ~$216K of TMO shares in the open market
  16. Mar 3, 2026Insider · 1 personInsiders: 12 sales (~$2.5M)
  17. Mar 4, 2026Insider · 1 personInsiders: 8 sales (~$2.6M)
  18. Mar 5, 2026Insider · 1 personInsiders: 13 sales (~$2.1M)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Thermo Fisher Scientific

For Thermo Fisher Scientific, OQRO holds 26 insider filings (SEC Form 4 or Form 144), 6 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TMO page.

Other recent filings by Gianluca Pettiti, Executive Vice President

The full history of Gianluca Pettiti, Executive Vice President is on the profile page.

How this filing works

Explore the data

Common questions

Which Thermo Fisher Scientific (TMO) insider traded, and how much?

Gianluca Pettiti, Executive Vice President at Thermo Fisher Scientific, sold ~$1.3M of Thermo Fisher Scientific shares. 2,250 shares at $580.00.

When did it happen, and when was it made public?

Traded: Nov 10, 2025. Filed: Nov 12, 2025. That is 2 days between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Thermo Fisher Scientific recently?

For Thermo Fisher Scientific, OQRO holds 26 insider filings (SEC Form 4 or Form 144), 6 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days. They are listed on the TMO page.

Does this mean TMO stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Thermo Fisher Scientific

Everything OQRO holds on this company is on its TMO page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data